Covetrus North America, LLC
Dublin, OH Part of Henry Schein, Inc.
Company facts
- FY2025 rankings
-
Its parent company, Henry Schein, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Henry Schein, Inc. · Melville, NY
D6MTSKS115L9
-
Parent
Henry Schein, Inc. · Melville, NY
D6MTSKS115L9
- SAM.gov registration date
- Physical address
- 400 Metro Pl N #100, Dublin, OH 43017, USA
- Website
- covetrus.com
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $714,271 |
| FY2025 | $586,846 |
| FY2024 | $1,151,473 |
| FY2023 | $881,760 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $573,900 | |
| 2 | Defense Logistics Agency | $140,408 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Atipamezole hydroch | Medical Supply Chain (DLA) | $777 | |
| Mouth guard, canine | Medical Supply Chain (DLA) | $19 | |
| Mouth guard, canine | Medical Supply Chain (DLA) | $38 | |
| Butorphanol tartrat | Medical Supply Chain (DLA) | $232 | |
| Butorphanol tartrate injectio | Medical Supply Chain (DLA) | $1,855 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Zoetis Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Antech Diagnostics, Inc. | Fountain Valley, CA | 541940 Veterinary Services |
| Old Dominion Animal Health Center, LTD. | McLean, VA | 541940 Veterinary Services |
| Vmrd Inc. | Pullman, WA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Sweetwater Veterinary Hospital, LLC | Palmetto, GA | 541940 Veterinary Services |
About the company
Covetrus North America, LLC, a subsidiary of Henry Schein, Inc. headquartered in Dublin, Ohio, supplies veterinary pharmaceuticals, medical devices, and parasiticides to federal agencies as a prime contractor competing full-and-open, with no SBA set-aside designations across its federal footprint. The company operates as a for-profit limited liability company and competes on commercial terms across 1,500 prime awards spanning 25 distinct federal customer agencies.
Covetrus North America's federal work concentrates heavily on veterinary pharmaceutical supply. The company's capability portfolio centers on controlled and non-controlled veterinary drugs (dexmedetomidine hydrochloride, tiletamine, butorphanol tartrate, pentobarbital sodium, atipamezole, carprofen, enrofloxacin, acepromazine), parasiticides (Coumaphos Co-Ral Flowable Form insecticide), veterinary medical supplies and diagnostic reagents (blood typing test kits, otic cleansing solutions, rabies vaccine), and related animal health products. Representative prime work includes a $4.5 million single-award indefinite delivery contract with the Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services division for Coumaphos Co-Ral parasiticide supporting the Cattle Fever Tick Eradication Program along the Texas-Mexico border, with a $524,830 delivery order issued in September 2025; a $573,900 definitive contract with USDA Veterinary Services for Negasunt Powder and Tanidil awarded in June 2026; and hundreds of small firm fixed-price purchase orders from the Defense Logistics Agency Medical Supply Chain for veterinary pharmaceuticals ranging from several dollars to several thousand dollars each.
Customer concentration skews dramatically toward the Defense Logistics Agency Troop Support Medical division, which accounts for 1,361 awards (91% of award count) but carries only $1.1 million in combined potential value—signaling high-volume, low-value transactional purchasing. The top five customer agencies by award count cover 97% of recent awards. By potential value, however, the Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services dominates with 8 awards worth $10.4 million combined (70% of the company's total federal potential value), while DLA Troop Support Medical represents a secondary value stream. This divergence reflects the vendor's dual positioning: high-frequency small orders from defense logistics supply channels and larger strategic contracts anchored to agriculture animal health initiatives. The Department of the Army Medical Command (50 awards, $969 thousand), the Department of the Air Force Air Education and Training Command (2 awards, $894 thousand), and the Smithsonian Institution (10 awards, $99 thousand) round out the active federal customer set.
Covetrus North America holds two named indefinite delivery contracts: an IDC valued at $2.3 million with 3 task orders and a second IDC valued at $525 thousand with 1 task order. The parent $4.5 million APHIS Veterinary Services IDC (12639522D0054) extends through December 31, 2028 and serves as the vehicle for parasiticide procurement supporting border-region tick control operations. Recent activity shows a mixed trajectory—133 awards in 2022 grew to a peak of 244 in 2023, then declined to 155 in 2024 and 83 in 2025 before recovering to 137 in 2026. The vendor faces limited near-term recompete pressure: only one award reaches ultimate completion within the next twenty-four months, carrying $574 thousand in potential value. Combined obligated dollars across all awards total $5.8 million (39% of $14.8 million combined potential value), indicating a significant pipeline of task orders and purchase orders not yet funded.
The vendor's award footprint concentrates in pharmaceutical manufacturing (NAICS 325412, 1,031 awards) and veterinary-use drugs and biologicals (PSC code, 1,126 awards), with secondary exposure in surgical supplies, medical instruments, diagnostic reagents, and imaging equipment. As a wholly owned subsidiary of Henry Schein, Inc.—a large publicly traded animal health distributor—Covetrus North America operates with no SBA certifications and does not participate in set-aside vehicles, competing exclusively in full-and-open federal procurement against commercial and other large vendors. The company's federal presence is functionally a transactional supply channel for veterinary pharmaceuticals and medical products flowing through defense logistics and civilian agricultural health networks rather than a strategic prime contractor.
Quick answers
Is Covetrus North America, LLC registered in SAM.gov?
Yes. Covetrus North America, LLC's SAM.gov registration is active through June 15, 2027.
What is Covetrus North America, LLC's CAGE code?
Covetrus North America, LLC's CAGE code is 4PG41, and its Unique Entity ID (UEI) is D8YKN6NHLLD4.
How much has Covetrus North America, LLC received in federal contracts?
Federal contracts obligated $586,846 to Covetrus North America, LLC in fiscal year 2025 and $3,334,349 in fiscal years 2023 through 2027.
How does Covetrus North America, LLC rank among federal contractors?
Covetrus North America, LLC's parent company, Henry Schein, Inc., ranked #4 in PSC 6840, #6 in NAICS 32532 and #8 in NAICS 3253 in FY2025.
What is Covetrus North America, LLC's most recent federal award?
Covetrus North America, LLC's most recent federal contract award is Atipamezole hydroch (SPE2DP26P1083), from Medical Supply Chain (DLA), on August 3, 2026.
On GovTribe
See Covetrus North America, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors